buspirone has been researched along with Diseases, Metabolic in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D | 1 |
| Pagire, HS | 1 |
| Pagire, SH | 1 |
| Bae, EJ | 1 |
| Dighe, M | 1 |
| Kim, M | 1 |
| Lee, KM | 1 |
| Jang, YK | 1 |
| Jaladi, AK | 1 |
| Jung, KY | 1 |
| Yoo, EK | 1 |
| Gim, HE | 1 |
| Lee, S | 1 |
| Choi, WI | 1 |
| Chi, YI | 1 |
| Song, JS | 1 |
| Bae, MA | 1 |
| Jeon, YH | 1 |
| Lee, GH | 1 |
| Liu, KH | 1 |
| Lee, T | 1 |
| Park, S | 1 |
| Jeon, JH | 1 |
| Lee, IK | 1 |
| Ahn, JH | 1 |
1 other study available for buspirone and Diseases, Metabolic
| Article | Year |
|---|---|
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglyc | 2019 |